Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 11/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.33 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15825699 | 0.80 | HCAR2 (0.58) | HCAR2 | |
| SCHEMBL27764731 | 0.80 | HCAR2 (0.53) | ALOX15HCAR2KMT2ATSHR | |
| SCHEMBL570053 | 0.80 | HCAR2 (0.50) | HCAR2KMT2A | |
| SCHEMBL9912568 | 0.74 | ABCC8 (0.54) | ALOX15HCAR2ABCC8KCNJ11 | |
| SCHEMBL32678646 | 0.73 | HCAR2 (0.41) | HCAR2KMT2ATSHR | |
| SCHEMBL32678645 | 0.73 | HCAR2 (0.41) | HCAR2KMT2ATSHR | |
| SCHEMBL29129797 | 0.72 | HCAR2 (0.35) | HCAR2 | |
| SCHEMBL4591235 | 0.71 | GYS1 (0.51) | ALOX15KMT2AL3MBTL1 | |
| SCHEMBL1929855 | 0.71 | HCAR2 (0.34) | HCAR2 | |
| SCHEMBL22578794 | 0.69 | ALOX15 (0.35) | ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026043973-A1 | POLY-METHYLATED, FLUORINE-FREE SUPERHYDROPHOBIC COMPOSITIONS, METHODS, AND/OR USES THEREOF | UNIVERSITY OF NORTH TEXAS (US) | 2026-02-26 | — | — | WO | disclosed |
| US-20090143440-A1 | Pyrazoles Useful in the Treatment of Inflammation | BIOLIPOX AB (SE) | 2009-06-04 | — | — | US | disclosed |
| US-20090143455-A1 | Pyrazoles Useful in the Treatment of Inflammation | BIOLIPOX AB (SE) | 2009-06-04 | — | — | US | disclosed |
| EP-1937645-A1 | PYRAZOLES USEFUL IN THE TREATMENT OF INFLAMMATION | Biolipox AB (SE) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007045868-A1 | PYRAZOLES USEFUL IN THE TREATMENT OF INFLAMMATION | BIOLIPOX AB (SE) | 2007-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143440-A1 | Pyrazoles Useful in the Treatment of Inflammation | ALOX15, ALOX12, ALOX15B | ALOX15 1/4885HCAR2 488/4885KMT2A 4450/4885 |
| US-20090143455-A1 | Pyrazoles Useful in the Treatment of Inflammation | ALOX15, ALOX12, ALOX15B | ALOX15 1/4885HCAR2 580/4885KMT2A 4432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.